Combipack of Ticagrelor Tablets IP 90 Mg & Aspirin Gastro-resistant Tablets IP 75 Mg – Dual Antiplatelet Combikit for Cardiovascular Protection.
PROLINTA AS Kit Tablets: The Composition of Combikit of Ticagrelor 90mg + Aspirin Gastro Resistant 75mg is a fixed-dose combination pack designed for dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) and post-PCI patients. Ticagrelor offers reversible and potent P2Y₁₂ inhibition, while Aspirin prevents thromboxane-mediated platelet aggregation. Together, they reduce atherothrombotic risk in high-risk cardiac patients.
Recommended by Specialists:
✅Cardiologists: It is preferred to treat the disease associated with Acute Coronary Syndrome (ACS), Myocardial Infarction (MI), and post-PCI (stent placement) to prevent thrombosis
✅Internal Medicine Specialists: It is preferred to treat the disease associated with ongoing secondary prevention in high-risk heart patients (under cardiology guidance).
Key benefits of Combipack of Ticagrelor Tablets IP 90 Mg & Aspirin Gastro-resistant Tablets IP 75 Mg – PROLINTA AS Kit Tablets:
✅Synergistic Platelet Inhibition—Ticagrelor (P2Y₁₂ inhibitor) and Aspirin (a COX-1 blocker) act via complementary mechanisms to prevent thrombus formation.
✅Reduced Risk of Recurrent Ischemic Events – Proven efficacy in lowering rates of MI, stroke, and cardiovascular death in ACS patients.
✅Convenient Fixed-Dose Kit – Simplifies dual therapy compliance with optimal dosing in a single daily-use pack.
INDICATIONS:
✅Acute Coronary Syndrome (ACS)
✅Post-Myocardial Infarction
✅Post-Angioplasty / Stent Placement
✅Dual Antiplatelet Therapy
✅Prevention of Recurrent Ischemic Events









